Stay updated with breaking news from Michelle Dipp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mizuho upgraded shares of Verastem (NASDAQ:VSTM – Get Rating) from a neutral rating to a buy rating in a research report released on Thursday, The Fly reports. The firm currently has $36.00 price target on the biopharmaceutical company’s stock, up from their previous price target of $24.00. Several other research firms have also recently weighed […]
Mizuho upgraded shares of Verastem (NASDAQ:VSTM – Get Rating) from a neutral rating to a buy rating in a research report released on Thursday, The Fly reports. Mizuho currently has $36.00 price target on the biopharmaceutical company’s stock, up from their prior price target of $24.00. VSTM has been the topic of a number of […]
Verastem, Inc. (NASDAQ:VSTM – Get Rating) has been assigned an average recommendation of “Buy” from the six analysts that are covering the firm, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy recommendation. The average 1-year price target among analysts that have updated their coverage on the stock in the last […]
StockNews.com initiated coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a research note issued to investors on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other analysts have also issued reports about the stock. Cantor Fitzgerald restated an overweight rating on shares of Verastem in a research note on […]
StockNews.com assumed coverage on shares of Verastem (NASDAQ:VSTM – Get Rating) in a report released on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. VSTM has been the subject of a number of other reports. HC Wainwright decreased their price objective on Verastem from $3.00 to $2.00 in a report […]